Navigation Links
Codeine use and accident risk
Date:3/24/2009

The risk of being involved in a traffic accident with personal injury is significantly higher among codeine users than non-users. However, sporadic or moderate use of codeine alone does not carry an increased risk, according to a newly published study from the Norwegian Institute of Public Health.

Codeine and tramadol are painkillers in the opiate group, used for mild to moderate pain. In Norway, codeine is included in Paralgin forte and Pinex forte, and tramadol, amongst others, in Nobligan. Norway has a higher consumption of codeine preparations than other European countries.

Earlier studies have given conflicting results when evaluating traffic accident risk linked to the use of codeine and tramadol. In this new study from the Norwegian Institute of Public Health, anonymised data from the Norwegian Prescription Database and Road Traffic Accident Register was used to study whether codeine- or tramadol users have an increased risk of being involved in a traffic accident with personal injury.

During the 33 months of the study, 181 road traffic accidents were registered with personal injury where the driver had been exposed to codeine and 20 after exposure to tramadol. "Exposure" is defined as the first 7 days after the dispensing of a prescription for a codeine- or tramadol preparation.

The study showed that the risk of being involved in a road traffic accident with personal injury was twice as high in the period after having a prescription for codeine dispensed. For those who had used more than approximately 400 tablets per year, the risk of being involved in a traffic accident was 3 times as large. When the use of other potential impairing medicines was excluded, the risk of accident sank significantly. For sporadic codeine users there was no increased risk of accident. There was not a significantly higher risk for tramadol.

- We have previously seen that large users of codeine preparations often use benzodiaz
'/>"/>

Contact: Julie Johansen
julie.johansen@fhi.no
Norwegian Institute of Public Health
Source:Eurekalert

Page: 1 2

Related biology news :

1. Codeine not safe for all breastfeeding moms and their babies
2. Small-scale fishing in Mexico rivals industrial fisheries in accidental turtle deaths

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...of using recordings of birdsong to accurately meas...t time sound recordings from a microphone array ha... species, populations. Because the new technique, ...nal of Applied Ecology , will also work with whale...lity to monitor whale and dolphin numbers. , Dev...
(Date:11/25/2009)...nia Institute of Technology (Caltech) have uncover...n the fruit fly, Drosophila melanogaster . , Th...nship between the neurotransmitter dopamine and at... described in the December issue of the journal N...bout 20,000 neurons and has long been considered a...
(Date:11/25/2009)...he linchpin of the environment, where atmosphere, ...y students see soil as "just dirt" a place to gro... are challenged with the task of helping students ...f soil in the environment. , A collaborative pr...t University of Nebraska-Lincoln, Oregon State Uni...
Breaking Biology News(10 mins):Ecologists sound out new solution for monitoring cryptic species 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4It's not just dirt! 2First Site in CalRHIOs Statewide Health Information Exchange Goes Live in Orange County 59493 1First Site in CalRHIOs Statewide Health Information Exchange Goes Live in Orange County 59493 2First Site in CalRHIOs Statewide Health Information Exchange Goes Live in Orange County 59493 3Improved diet and exercise alone unlikely to cure obstructive sleep apnea in obese patients 10363 1Improved diet and exercise alone unlikely to cure obstructive sleep apnea in obese patients 10363 2Data from Jazz Pharmaceuticals First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences 5493 1Data from Jazz Pharmaceuticals First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences 5493 2Data from Jazz Pharmaceuticals First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences 5493 3
...archers are working toward a future in which each ...aling how oncologists should treat the cancer to o...annot predict which patients with prostate cancer ...ether some of these patients have an indolent dise...nts with colorectal cancer have surgery, but some,...
...e researchers, in partnership with Affymetrix, Inc...me Array ?that can improve citrus varieties and su...mine which genes are turned on in a tissue of citr...ontent and disease, for example ?the chip provides...existing problems and making improvements to the f...
...nex or Xanax? Or maybe Zantac? If you,re a health ...--mistakes can be fatal. , An estimated 1.3 millio...ch year from medication errors, and the U.S. Feder...educe the possibilities of these errors, such as a...ction of Narcan but received Norcuron and went int...
Other Biology News:AIDS-related cognitive impairment exists in two separate forms 2AIDS-related cognitive impairment exists in two separate forms 3AIDS-related cognitive impairment exists in two separate forms 4AIDS-related cognitive impairment exists in two separate forms 5AIDS-related cognitive impairment exists in two separate forms 6AIDS-related cognitive impairment exists in two separate forms 7UCR researchers design chip that can improve citrus varieties 2UCR researchers design chip that can improve citrus varieties 3Computer scientist sorts out confusable drug names 2
(Date:11/24/2009)...CALGARY and BLENHEIM, Ontario, Nov. 24 /PRNewswire...oday it is acquiring the assets of Hyland Seeds, a...o. The addition of Hyland Seeds will further expan...company anticipates the introduction of SmartStax...olerant Trait Technology in corn in 2012. The tran...
(Date:11/24/2009)..., SHANGHAI, Nov. 24 /PRNewswire-Asia/ -- NOD ... Trademark Office (PTO) has allowed the patent app...D technology. , NOD technology is a highl...oteins into bio-adhesive nano-particles to enable ...njections. NOD technology is a platform technology...
(Date:11/24/2009)... , Primary efficacy endpoint has been met for p...etrial cancer, , QUEBEC CITY, Nov. 24 /PRNews...AEZS ; TSX: AEZ) (the "Company"), a global biophar...d oncology, today announced positive efficacy data...peptide conjugate, AEZS-108 (formerly AN-152), in ...
(Date:11/24/2009)...N,Italy,November24/PRNewswire/--HealthRoboticstoda...withagroupofselected,investors.ThisrecentlyformedT...oboticsCanada,Inc.andwillmarket,install,andsupport...cludesthe,revolutionaryproductofferingsi.v.STATION...Inc.willalsoprovideassistanceonan"asneeded,basis"t...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2
..., 2007, 11:30 a.m. ET -, REDWOOD CITY, Calif., Oc...conference call to discuss the company,s third,qua... a.m. PT) on Thursday,November 1, 2007. Russell Ho... the call. A press release announcing Maxygen,s th...earlier that same day at approximately,9:00 a.m. E...
...ct. 19 AMERIGROUP,Corporation (NYSE: AGP ) today...rld Markets 18th Annual Healthcare Conference on N...he Company,s presentation, which begins Monday,Nov...d on AMERIGROUP,s Web,site, http://www.amerigroup...e,available for 30 days, and can be accessed at th...
...19 BioWa, Inc. (BioWa) announced,today that it ha...,GlaxoSmithkline (GSK) with access to BioWa,s pate...velopment of antibody-dependent cellular,cytotoxic...nts GSK non-exclusive rights to research and devel...or an undisclosed number of,targets. In return, Bi...
Other Biology Technology:Maxygen Third Quarter 2007 Financial Results Conference Call Notice 2BioWa Announces Licensing of BioWa's POTELLIGENT(R) Technology by GlaxoSmithkline for Use in Antibody Research and Development 2
...-neo-FRT-loxP template is designed to allow kanam...tic cells, respectively. It combines a prokaryoti...tance in E.coli with a eukaryotic promoter (PGK)...n cells. The prokaryotic promoter gb2 is a slight...
pORF39-Hph from InvivoGen
...-neo-loxP template is designed to allow neomycin/k...ells. The loxP-PGK-gb2-neo-loxP template encodes ...nes a prokaryotic promoter (gb2) for expression of...promoter (PGK) for expression of neomycin resistan...
...he kit provides a simple and efficient means for i...ing annexin V magnetic beads (MagBeads). Annexin V...with high affinity for phosphatidylseri The Apopt...cient means for isolation of apoptotic cells or re...
Biology Products: